Darxicilib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Darxicilib, covering 2024-07-15 to 2024-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. [Phase 2]